PF-28475 |
ROLIMAX 250, 250 mg/5mL Granulado para suspensión oral |
2022-05-29 |
|
Novoswiss Pharmaceuticals |
Guatemala
|
Novoswiss Pharmaceuticals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-28480 |
ROLIMAX 125, 125 mg/5mL Granulado para suspensión oral |
2022-05-29 |
|
Novoswiss Pharmaceuticals |
Guatemala
|
Novoswiss Pharmaceuticals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-13337 |
EFECTINE 10 mg Tabletas |
2028-01-21 |
|
Unipharm International, S.A. |
Guatemala
|
Medicin Farmacéutica |
Novoswiss Pharmaceuticals |
Centro Distribuidor, Sociedad Anónima |
Medwell International |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-9013 |
NEOBOL Aerosol Suspensión |
2028-02-14 |
|
Novoswiss Pharmaceuticals |
Guatemala
|
Medwell International |
Novoswiss Pharmaceuticals, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-21630 |
TERBIX 1 % Crema tópica |
2027-11-17 |
|
Unipharm International, S.A. |
Guatemala
|
Novoswiss Pharmaceuticals |
Medwell International |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-5325 |
UNIPULMIN BALSAMICO ungüento topico |
2019-11-16 |
|
Novoswiss Pharmaceuticals |
Guatemala
|
Novoswiss Pharmaceuticals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-22833 |
NODIK 100 mg/ 5 mL Polvo para Suspension |
2029-06-20 |
|
Unipharm International, S.A. |
Guatemala
|
Medicin Farmacéutica |
Centro Distribuidor, Sociedad Anónima |
Medwell International |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-53249 |
HERBALIFE 24 REBUILD STRENGTH SABOR CHOCOLATE Polvo oral |
2021-09-05 |
|
Herbalife International Inc. |
Estados Unidos de América
|
Logicom De Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-53701 |
HERBALIFE TE CONCENTRADO DE HIERBAS Polvo para solución oral |
2022-01-13 |
|
Herbalife International Inc. |
Estados Unidos de América
|
Logicom De Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-53795 |
HERBALIFE NITEWORKS Polvo oral sabor limón |
2026-10-18 |
|
Herbalife International Luxembourg S.a.R.L. |
Estados Unidos de América
|
Logicom De Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|